Dr. Brock Liden, an internationally recognized podiatrist with more than 25 years of experience in chronic wound management, delivered one of the most engaging sessions at SAWC Fall 2025. His presentation explored how consistent wound-bed management and supportive topical therapy can help drive wound progression in both diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).
Dr. Liden began by acknowledging a common challenge across wound care today: patients often present with long-standing wounds shaped by multiple comorbidities, recurring inflammation, and delayed progression despite appropriate debridement and standard care. In this environment, clinicians are increasingly looking for treatments that help maintain a stable, supportive wound environment between visits — especially when patients are responsible for daily care at home.
While Bonvadis® is cleared as a full-thickness wound topical device, Dr. Liden shared his clinical observations on how patients responded when it was incorporated into their care plans. In his experience, supporting the wound bed consistently after debridement helped many wounds demonstrate visible progress earlier in the course of treatment.
DFU Case Series
- 48-year-old male, 58-week DFU → closed in 3 weeks
- 47-year-old female, 8-week plantar DFU → closed in 4 weeks
- 48-year-old female, long-standing DFU with HBA1C 10.8% → closed in 7 weeks
VLU Case Series
- 70-year-old male, 21 cm² venous ulcer → 0 cm² in 4 weeks
- 65-year-old female, 16–31 cm² ulcer → full closure in 4 weeks
Across both etiologies, the patterns were clear:
- Fast reduction in wound size within 1–2 weeks
- Consistent progression post-debridement
- Ease of use, supporting continuity between visits
- Compatibility with NPWT, SOC, offering flexible integration into workflow
Dr. Liden emphasized that as wound care grows more complex—older patients, more comorbidities, higher expectations—clinicians need therapies that not only close wounds but also actively modulate the wound environment to support quality healing.
His session highlighted how wound bed optimization is becoming a central pillar of modern wound management, bridging the gap between chronicity and closure.
